Home / Pharmaceutical company intelligence
shrooq pharmaceuticals pvt ltd site mark
Pharmaceutical company intelligence

shrooq pharmaceuticals pvt ltd

Manufacturer Holds a DRAP Drug Manufacturing Licence (DML) for its products. Source: DRAP.

Follow price changes 🔒 Company report (Pharma Pro)

Private pharmaceutical manufacturer · Lahore · Pakistan

Lahore-based pharmaceutical manufacturer operating from Ferozepur Road and producing medicines for local and contract-manufacturing markets.

Sourced corporate profile Corporate identity fields are source-tracked; portfolio, price and competitor intelligence remains independently calculated by MedInfoBase.
Official website ↗
ShareSend this page
Evidence & freshness

What is sourced, and how recent is it?

Public-source corporate details
Latest regulatory-source observation29 Sep 2026Newest linked source record observed by MedInfoBase
Latest portfolio source check9 Aug 2026Latest source-check date across this published portfolio
Latest effective price date4 Aug 2026Newest effective date among published current price records
Corporate profile evidence3 sourcesCorporate source details checked 16 Aug 2026

Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.

Regulatory & corporate identity

Company profile

Public-source corporate details
Legal / official name
Shrooq Pharmaceuticals (Pvt.) Ltd.
Company type
Private pharmaceutical manufacturer
Address
21-KM Ferozepur Road, Lahore 54000, Pakistan · 54000
Corporate source details checked
16 Aug 2026
Corporate profile completeness
63%
DRAP manufacturing licenceAs published by the DRAP Licensing Division. DRAP issues this list for stakeholder review and states it is not a reference for litigation, claims or citation.
Formulation 000577 Shrooq Pharmaceuticals (Pvt) Ltd. · Punjab
Source-linked licence identifiersShown as recorded in linked source rows; not a claim of current validity.
DML 000577 2 linked products · source seen 29 Sep 2026 View source ↗
Corporate profile source ledger Logo Source Url source ↗
Location intelligence

Company location

Google Maps
Location recorded

A sourced company location is recorded. Use the map link below for directions.

Open in Google Maps ↗
Intelligence snapshot

Portfolio at a glance

Not sales data · published MedInfoBase database view
Rx125public portfolio records represented
REG125unique registrations represented
IDX2indexed MedInfoBase presentations
SRC0additional source-observed presentations
R+123registry-only registrations
VER2registry-verified exact registrations
PKR2current validated price records
G1generic molecules in indexed catalogue
DF1dosage-form groups
TA1therapeutic areas
How to read these counts

RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.

PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.

IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.

Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.

Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.

Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.

Data coverage

How complete is this profile?

Current price coverage2%
public portfolio presentations with a validated current price
Official-source coverage100%
products linked back to a source record
Unit-price parse coverage100%
priced packs safely normalized per unit
Comparable-market coverage100%
products with at least one like-for-like comparator
Therapeutic classification100%
products assigned to a broad therapeutic area
Visual intelligence

Downloadable company intelligence charts

Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.

Shareable intelligence

Therapeutic Portfolio Mix

Shows where the company portfolio is concentrated across broad therapeutic areas.

Therapeutic Portfolio Mixshrooq pharmaceuticals pvt ltdShare of current product presentations by broad therapeutic areaMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/shrooq-pharmaceuticals-pvt-ltdGenerated 29 Sep 2026Anti-infectives2 · 100%Percentages are based on current product presentations in the MedInfoBase company portfolio.

Portfolio distribution, not sales or market-share data.

Shareable intelligence

Dosage Form Portfolio

Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.

Dosage Form Portfolioshrooq pharmaceuticals pvt ltdDistribution of current product presentations by normalized dosage formMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/shrooq-pharmaceuticals-pvt-ltdGenerated 29 Sep 20262presentationsSuspension2 · 100%Dosage-form wording is normalized for intelligence display; original source wording remains preserved in product records.

Counts are product presentations, not production or sales volumes.

Shareable intelligence

Equivalent Price Position

Shows whether safely comparable products are below, near or above the peer median unit price.

Equivalent Price Positionshrooq pharmaceuticals pvt ltdCurrent company products compared with like-for-like equivalent medicines using normalized unit pricesMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/shrooq-pharmaceuticals-pvt-ltdGenerated 29 Sep 20262comparable productsBelow peer median2 · 100%Near peer median0 · 0%Above peer median0 · 0%Company median price position-48.3%Lowest-price equivalents2Method: same generic + stated strength + dosage form + compatible unit basis; pack prices normalized per unit.

This is price-position intelligence, not sales, demand or market-share data.

Shareable intelligence

Closest Portfolio Competitors

Highlights other manufacturers with the greatest generic overlap with this company portfolio.

Closest Portfolio Competitorsshrooq pharmaceuticals pvt ltdCompanies with the largest number of shared generic medicines in the MedInfoBase databaseMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/shrooq-pharmaceuticals-pvt-ltdGenerated 29 Sep 2026Nabiqasim Industries (Pvt) Ltd.,1 shared100% overlapM/s. Genix Pharma (Pvt) Ltd.1 shared100% overlapGetz Pharma (Pvt) Limited1 shared100% overlapHilton Pharma (Pvt) Limited.1 shared100% overlapPharmasol (Pvt) Ltd.1 shared100% overlapBosch Pharmaceuticals (Pvt) Ltd.1 shared100% overlapPortfolio overlap measures shared generics only; it is not a measure of market share, affiliation or sales competition.

Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.

Portfolio intelligence

Therapeutic areas

Broad portfolio view

High-level clinical areas represented by this company’s current MedInfoBase portfolio.

Pharmacological detail

Drug classes

More specific view

More specific classes derived from the canonical generic and preserved curated classifications.

Formulation footprint

Dosage forms

Suspension2 products
How MedInfoBase classifies the portfolio

MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.

Portfolio leaders

Deepest brand families

Ranked by registered presentations · not sales
Price intelligence

Unit-price positioning vs equivalent products

Same generic + strength + form + unit basis
🔒
MedInfoBase Pharma Pro

See where shrooq pharmaceuticals pvt ltd is priced against the market

2 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.

Below / near / above medianCompany price positionProduct examplesExcel, PDF & PowerPoint
Unlock with Pharma Pro
How MedInfoBase calculates price position

Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.

Competitive landscape

Portfolio overlap

Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.

🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock

Regulatory & price activity

Observed database signals

Indexed registration numbers2Distinct registrations among indexed, published, presentation-validated products only
Verified price observations2
Products with a verified price2
Products with multiple price observations0
Source records with multiple versions2
Latest portfolio source check9 Aug 2026
Latest effective price date4 Aug 2026
Latest source observation29 Sep 2026

These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.

Company medicine portfolio

Medicine portfolio

125 unique registration(s) · 2 indexed presentation(s) · 123 registry-only registration(s)

This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.

Reset
BrandGenericStrengthFormPackRegistrationSource-listed priceUnit pricePrice position
Esomalt Capsule 40mgRegistry verified Esomeprazole as Magnesium trihydrate enteric Coated Pellets ...... 40 mg — Capsule — 060400Official source ↗ No indexed price — —
Esozil 20mg TabletRegistry verified Esomeprazole as magnesium trihydrate ...... 20 mgEsomeprazole (As Magnesium trihydrate) ...... 20 mg — Tablet — 048945Official source ↗ No indexed price — —
Esozil 40mgTabletRegistry verified Esomeprazole as magnesium trihydrate ...... 40 mg — Tablet — 048946Official source ↗ No indexed price — —
Etrin CreamRegistry verified Isoconazole Nitrate ...... 10 mgDiflucortolone valerate ...... 1 mg — Cream — 054042Official source ↗ No indexed price — —
Fdin 60mg TabletsRegistry verified Fexofenadine hydrochloride ...... 60 mg — Tablet — 040301Official source ↗ No indexed price — —
Fenorat Capsule 134mgRegistry verified Fenofibrate ...... 134 mg — Capsule — 060797Official source ↗ No indexed price — —
Fenorat Capsule 200mgRegistry verified Fenofibrate ...... 200 mg — Capsule — 060796Official source ↗ No indexed price — —
Fenorat Capsule 67mgRegistry verified Fenofibrate ...... 67 mg — Capsule — 060795Official source ↗ No indexed price — —
Fenorat TabletRegistry verified Fenofibrate (micronized ...... 160 mg — Tablet — 060618Official source ↗ No indexed price — —
Fepizen Injection 1gmRegistry verified Cefepime as hydrochloride ...... 1 g — Injection — 065817Official source ↗ No indexed price — —
Feriwin 40mg SyrupRegistry verified Iron Protein Succinylate ...... 40 mg — Syrup — 055216Official source ↗ No indexed price — —
Fomen 20mg TabletRegistry verified Famotidine ...... 20 mg — Tablet — 040310Official source ↗ No indexed price — —
Fomen 40mg TabletRegistry verified Famotidine ...... 40 mg — Tablet — 040311Official source ↗ No indexed price — —
Fomen Suspension 10mgRegistry verified Famotidine ...... 10 mg — Suspension — 040312Official source ↗ No indexed price — —
Fusimin B CreamRegistry verified Fusidic acid ...... 2 tamethasone as valerate ...... 0.1 % — Cream — 040838Official source ↗ No indexed price — —
Fusimin CreamRegistry verified Fusidic acid ...... 2 % — Cream — 040837Official source ↗ No indexed price — —
Fusimin OintmentRegistry verified Fusidic acid ...... 2 % — Ointment — 040836Official source ↗ No indexed price — —
Gabmor Capsule 100mgRegistry verified Gabapentin ...... 100 mg — Capsule — 060390Official source ↗ No indexed price — —
Gabmor Capsule 300mgRegistry verified Gabapentin ...... 300 mg — Capsule — 060388Official source ↗ No indexed price — —
Gabmor Capsule 400mgRegistry verified Gabapentin ...... 400 mg — Capsule — 060389Official source ↗ No indexed price — —
Gabmor Tablets 600mgRegistry verified Gabapentin ...... 600 mg — Tablet — 062634Official source ↗ No indexed price — —
Garnet Injection 1gmRegistry verified Cefoperazone as sodium ...... 1 g — Injection — 065812Official source ↗ No indexed price — —
Garnet Injection 250mgRegistry verified Cefoperazone as sodium ...... 250 mg — Injection — 065810Official source ↗ No indexed price — —
Garnet Injection 500mgRegistry verified Cefoperazone as sodium ...... 500 mg — Injection — 065811Official source ↗ No indexed price — —
Gemilox Tab 320mgRegistry verified Gemifloxacin ...... 320 mg — Tablet — 048348Official source ↗ No indexed price — —
Glare 100mg/5ml SuspensionRegistry verified Ibuprofen ...... 100 mg — Suspension — 040319Official source ↗ No indexed price — —
Glifor TabletRegistry verified Metformin HCL ...... 500 mgGlibenclamide ...... 5 mg — Tablet — 060463Official source ↗ No indexed price — —
Hirex 500mcg TabletsRegistry verified Mecobalamin ...... 500 mcg — Tablet — 057373Official source ↗ No indexed price — —
Isocef 400mg CapsuleRegistry verified Cefixime ...... 400 mg — Capsule — 040852Official source ↗ No indexed price — —
Isocef Cap 200mgRegistry verified Cefixime ...... 200 mg — Capsule — 048352Official source ↗ No indexed price — —
Isocef SuspensionRegistry verified Cefixime ...... 100 mg — Suspension — 040853Official source ↗ No indexed price — —
Isocef-DS Dry SuspRegistry verified Cefixime ...... 200 mg — Suspension — 048349Official source ↗ No indexed price — —
Isonex Capsule 10mgRegistry verified Isotretinoin ...... 10 mg — Capsule — 060799Official source ↗ No indexed price — —
Isonex Capsule 20mgRegistry verified Isotretinoin ...... 20 mg — Capsule — 060798Official source ↗ No indexed price — —
Joinix SachetRegistry verified Glucosamine as sulphate ...... 500 mgChondroitin as Sulphate ...... 400 mg — Powder for Solution — 062632Official source ↗ No indexed price — —
Kenvid 200mg TabletRegistry verified Ofloxacin ...... 200 mg — Tablet — 040292Official source ↗ No indexed price — —
Lansoft Capsule 30mgRegistry verified Lansoprazole (Pellets ...... 30 mg — Capsule — 068088Official source ↗ No indexed price — —
Lefexy 500mg TabletsRegistry verified Levofloxacin (as hemihydrate) ...... 500 mg — Tablet — 040295Official source ↗ No indexed price — —
Lefexy Tablet 250mgRegistry verified Levofloxacin (as hemihydrate) ...... 250 mg — Tablet — 040294Official source ↗ No indexed price — —
Lortin 5mg SuspensionRegistry verified Loratadine ...... 5 mg — Suspension — 040300Official source ↗ No indexed price — —
Lortin TabletRegistry verified Loratadine ...... 10 mg — Tablet — 040298Official source ↗ No indexed price — —
Loxirax 15mg TabletRegistry verified Meloxicam ...... 15 mg — Tablet — 040309Official source ↗ No indexed price — —
Loxirax 7.5mg TabletRegistry verified Meloxicam ...... 15 mg — Tablet — 040308Official source ↗ No indexed price — —
M-Cip Tablet 250mgRegistry verified Ciprofloxacin as HCl ...... 250 mg — Tablet — 040291Official source ↗ No indexed price — —
M-Cip Tablet 500mgRegistry verified Ciprofloxacin as HCl ...... 500 mg — Tablet — 040290Official source ↗ No indexed price — —
Marvel Tablet 5mgRegistry verified Levocetirizine dihydrochloride ...... 5 mg — Tablet — 042979Official source ↗ No indexed price — —
MaxArt CapsuleRegistry verified Artemether ...... 80 mgLumefantrain ...... 480 mg — Capsule — 060387Official source ↗ No indexed price — —
Maxart CapsulesRegistry verified Artemether ...... 20 mgLumefantrain ...... 120 mg — Capsule — 060386Official source ↗ No indexed price — —
MaxArt DS CapsuleRegistry verified Artemether ...... 40 mgLumefantrain ...... 240 mg — Capsule — 060385Official source ↗ No indexed price — —
Maxbon TabRegistry verified Alendronate ...... 70 mg — Tablet — 048301Official source ↗ No indexed price — —
MedInfoBase company-intelligence methodology

This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.

Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.

Cite this record

Manufacturer record
MedInfoBase. (2026). shrooq pharmaceuticals pvt ltd — registered product portfolio in Pakistan [Data set]. MedInfoBase. Retrieved September 29, 2026, from https://medinfobase.com/company/shrooq-pharmaceuticals-pvt-ltd/
Download .RIS Download .BIB EndNote, Zotero, Mendeley, RefWorks

Records change over time. Please cite the access date so readers can locate the version you used.